Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 7
Submit an article Journal homepage
375
Views
9
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with everolimus (RAD001) and alemtuzumab: a Phase I/II study

Clive S. ZentDivision of Hematology, Mayo Clinic, Rochester, NY, USA; Correspondence[email protected]
,
Deborah A. BowenDivision of Hematology, Mayo Clinic, Rochester, NY, USA;
,
Michael J. ConteDivision of Hematology, Mayo Clinic, Rochester, NY, USA;
,
Betsy R. LaPlantDepartment of Health Sciences Research, Mayo Clinic, Rochester, NY, USA
&
Timothy G. CallDivision of Hematology, Mayo Clinic, Rochester, NY, USA;
Pages 1585-1591 | Received 02 Sep 2015, Accepted 20 Oct 2015, Published online: 24 Dec 2015
Supplemental material

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Download Zip (5.6 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.